Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented May Mobility in the transaction. May Mobility announced its $105 million Series D financing round, as part of its...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Star Therapeutics in the transaction. Star Therapeutics announced its oversubscribed $90 million Series C financing to continue growth of its...
You must be a Standard 1 Year member to access this content.
Osborne Clarke and Gunderson Dettmer advised G2 Venture Partners on its investment. 1KOMMA5° has raised €215 million in its Series B financing round. As a result,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised sales agents Goldman Sachs & Co. LLC and SVB Securities on the deal. Goldman Sachs & Co. LLC and SVB Securities acted as sales agents in...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Lightspeed Venture Partners on the deal while Mintz represented TRIANA Biomedicines. Lightspeed Venture Partners co-led the $110 million...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Neuron23 on the deal. Neuron23, a biotechnology company, announced its $100 million Series C financing led by SoftBank Vision Fund 2. Neuron23 focuses on...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Electra Therapeutics on the deal. Electra Therapeutics, a clinical-stage biotechnology company, announced its $84 million Series B financing co-led...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Seismic Therapeutic, Inc. on the deal while Gunderson Dettmer represented Lightspeed Venture Partners. Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
You must be a Standard 1 Year member to access this content.
